Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Atropine (0.02%, 0.04%) Combined With Defocus DIMS for Moderate and High Myopia Controleye disorder, myopia, refractive errorRecruitingPhase 1 / Phase 22025-09-08NCT06523504

2 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Beijing Tongren Hospital60
Ruihua Wei5

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Tianjin Medical University Eye HospitalTianjinChina4